For $1 billion, AstraZeneca acquires the French biotech company Amolyt.

Published Date: 20 Mar 2024

On Thursday, the French biotech specialist Amolyt Pharma was agreed to be acquired by the Anglo-Swedish pharmaceuticals giant AstraZeneca for approximately $1 billion, allowing the company to further enter the rare drug market.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Charles III, King of Kings, is Cancerous.

2.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

3.

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

4.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

5.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot